FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

These updates support Ocugen in its efforts to pursue its goal of 3 biologics license applications (BLA) in the next 3 years.

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...

Under the leadership of the U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. and the U.S.

The release involves an estimated 200,000 pages of records that had been under a court-imposed seal since 1977.

The FDA has named Dr. George Tidmarsh to lead its drug division, putting him at the helm of the agency’s drug approval ...

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...